Compare AVXL & KFRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVXL | KFRC |
|---|---|---|
| Founded | 2004 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.6M | 470.6M |
| IPO Year | N/A | 1995 |
| Metric | AVXL | KFRC |
|---|---|---|
| Price | $4.37 | $29.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | $22.00 | ★ $34.75 |
| AVG Volume (30 Days) | ★ 4.6M | 229.5K |
| Earning Date | 11-25-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 5.22% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.26 |
| Revenue | N/A | ★ $1,340,771,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.21 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.86 | $24.49 |
| 52 Week High | $14.44 | $61.52 |
| Indicator | AVXL | KFRC |
|---|---|---|
| Relative Strength Index (RSI) | 40.02 | 52.06 |
| Support Level | $3.62 | $29.00 |
| Resistance Level | $4.84 | $30.42 |
| Average True Range (ATR) | 0.42 | 1.05 |
| MACD | 0.23 | 0.02 |
| Stochastic Oscillator | 74.53 | 74.46 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.